Trial Profile
Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 27 May 2019
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 19 Mar 2019 Status changed from active, no longer recruiting to completed.
- 29 Mar 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Dec 2018.
- 13 Dec 2017 Planned primary completion date changed from 1 Dec 2020 to 1 Jan 2018.